Treatment of the Sicca syndrome and Sjogren's syndrome with E.F.A., pyridoxine and vitamin C.
D001205:Ascorbic Acid / Q000627:therapeutic use*; D005228:Fatty Acids, Essential / Q000627:therapeutic use*; D006801:Humans; D007766:Lacrimal Apparatus Diseases / Q000188:drug therapy*; D011736:Pyridoxine / Q000627:therapeutic use*; D012466:Salivary Gland Diseases / Q000188:drug therapy*; D012859:Sjogren's Syndrome / Q000188:drug therapy*; D013577:Syndrome
D005228:Fatty Acids, Essential; D011736:Pyridoxine; D001205:Ascorbic Acid